Leadership
GBM AGILE
About GBM AGILE
GBM AGILE Trial Sites
FAQs
Strategic Partners
REMAP-COVID
About REMAP-COVID
REMAP-COVID US Trial Sites
Ovarian CanceRx
News
Join Us
Contact
DONATE
< Back to News
Kintara Announces First European Site Activation in Switzerland in GCAR Phase 2/3 Clinical Trial for Glioblastoma
MAY 27, 2022 | PRNEWSWIRE
https://www.prnewswire.com/news-releases/kintara-announces-first-european-site-activation-in-switzerland-in-gcar-phase-23-clinical-trial-for-glioblastoma-301556420.html
Home
Leadership
About REMAP-COVID
REMAP-COVID US Trial Sites
Ovarian CanceRx
GBM AGILE
About GBM AGILE
GBM AGILE Trial Sites
FAQs
Strategic Partners
News
Join Us
Contact
DONATE